rss
Thorax 2008;63:201-207 doi:10.1136/thx.2006.068007
  • Chronic obstructive pulmonary disease

Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease

  1. M Albers,
  2. T Schermer,
  3. Y Heijdra,
  4. J Molema,
  5. R Akkermans,
  6. C van Weel
  1. Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  1. M Albers, Radboud University Nijmegen Medical Centre, Department of Primary Care [117-HAG], PO Box 9101, 6500 HB Nijmegen, The Netherlands; m.albers{at}hag.umcn.nl
  • Received 30 June 2006
  • Accepted 12 August 2007
  • Published Online First 28 September 2007

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is an insidiously starting disease. Early detection has high priority because of the possibility of early implementation of smoking cessation interventions. An evidence based model for case finding of COPD is not yet available.

Objective: To describe the early development of COPD, and to assess the predictive value of early signs (respiratory symptoms, lung function below the normal range, reversibility).

Design and methods: In a prospective study, based in general practice, formerly undiagnosed subjects (n = 464) were assessed at baseline and at 5 years for respiratory symptoms and pulmonary function. Odds ratios for early signs were calculated (adjusted for age, gender, pack-years at baseline and smoking behaviour during follow-up), and defined as possible indicators of disease progression.

Results: Over a 5 year period, the percentage of subjects with obstruction increased from 7.5% (n = 35) at baseline to 24.8% (n = 115) at 5 years. The presence of mild early signs and lung function below the normal range at baseline were related to an increased risk of developing mild to moderate COPD (GOLD I: OR 1.87 (95% CI 1.22 to 2.87); GOLD II: OR 2.08 (95% CI 1.29 to 3.37) to 2.54 (95% CI 1.25 to 5.19)) at 5 years.

Conclusion: Lung function below the normal range and early respiratory signs predict the development and progression of COPD.

Footnotes

  • Competing interests: None.

  • Ethics approval: Yes.

  • iScreening criteria, used to determine the respiratory status of subjects (see table A1 in appendix 1).

  • iiBaseline values of the several follow-up groups (see table A2 in appendix 1).

  • iiiTrial participants.

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Free archive
The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.